Citation Impact
Citing Papers
Rational Design of Intercellular Adhesion Molecule-1 (ICAM-1) Variants for Antagonizing Integrin Lymphocyte Function-associated Antigen-1-dependent Adhesion
2005 StandoutNobel
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug
2002
Psoriasis
2009 Standout
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Atopic dermatitis
2003 Standout
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
2008
Atopic dermatitis
2015 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Atopic dermatitis: New insights and opportunities for therapeutic intervention
2000
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
2002
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis
2001
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial
2005
Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study
2002
Small Molecule Integrin Antagonists that Bind to the β2 Subunit I-like Domain and Activate Signals in One Direction and Block Them in the Other
2003
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
2004
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
2002 Standout
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils
2001
Compression regimes after endovenous ablation for superficial venous insufficiency – A survey of members of the Vascular Society of Great Britain and Ireland
2015 StandoutNobel
European guidelines for sclerotherapy in chronic venous disorders
2013
Interrelationship between mean arterial blood pressure, blood flow, and vascular resistance in solid tumor tissue of DS-carcinosarcoma
1975
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial
2015
Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.
1989 Standout
Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis
2005
Hypoxia in neoplastic tissue
1977
Macrolactam Immunomodulators (Tacrolimus and Pimecrolimus): New Horizons in the Topical Treatment of Inflammatory Skin Diseases
2004
Works of Schulz being referenced
A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology
1999
Critical O2 and glucose supply and microcirculation in tumor tissue.
1973
Late stroke after foam sclerotherapy
2010